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with	a	sulfa	allergy?
evidence-based answer
Diuretics that do not contain a sulfonamide 
group (eg, amiloride hydrochloride, 
eplerenone, ethacrynic acid, spironolactone, 
and triamterene) are safe for patients with an 
allergy to sulfa. The evidence is contradictory 
as to whether a history of allergy to 
sulfonamide antibiotics increases the risk of 
subsequent allergic reactions to commonly 
used sulfonamide-containing diuretics  
(eg, carbonic anhydrase inhibitors, loop 
diuretics, and thiazides) (strength of 
recommendation: c, based on case series 
and poor quality case-control and cohort 
studies). 
clinical commentary
are all sulfa drugs created equal?
Historical bromides commonly fall by the 
wayside as better evidence becomes 
available. Who would have thought 15 
years ago that we would be promoting 
beta-blockers for patients with congestive 
heart failure? 
 likewise, with closer inspection, we 
have learned that not all sulfa drugs are 
created equal. The stereospecificity due 
to the absence of aromatic amines in 
common diuretics means they are safe 
for patients with known sulfa antibiotic 
allergies. Given that diuretics are older 
agents and off-patent, with no company 
to take up their cause, no one has been 
willing to challenge outdated package 
insert warnings. 
 As clinicians who regularly work 
without a net, we are accustomed to 
prescribing medications in less than ideal 
circumstances. Thankfully, reasonable 
evidence is available to support what many 
of us are already doing—using cheap 
thiazides for patients despite a history of 
sulfa allergy.
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z	Evidence	summary
Little research has been performed 
on sulfonamide antibiotic and sulfon-
amide diuretic allergic cross-reactivity. 
What we do know is that there are 2 
classes of sulfonamides—those with an 
aromatic amine (the antimicrobial sul-
fonamides) and those without (eg, the 
diuretics acetazolamide, furosemide, 
hydrochlorothiazide, and indapamide). 
Hypersensitivity reactions occur when 
the aromatic amine group is oxidized 
into hydroxylamine metabolites by the 
liver. Sulfonamides that do not contain 
this aromatic amine group undergo dif-
ferent metabolic pathways, suggesting 
that allergic reactions that do occur in 
this group are not due to cross-reactivity 
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The odds of  
an allergy to  
a nonantibiotic 
sulfonamide more 
than doubled  
if the patient had 
a history of allergy 
to a sulfonamide 
antibiotic
in sulfa-allergic patients. But that point 
is far from settled by the research. 
On	one	side,	a	large	cohort	study		
shows	some	cross-reactivity
A large retrospective cohort study us-
ing Britain’s General Practice Research 
Database identified 20,226 patients seen 
from 1987 through March 1999 who 
were prescribed a systemic sulfonamide 
antibiotic, and then at least 60 days later 
received a nonantibiotic sulfonamide (eg, 
thiazide diuretic, furosemide, oral hypo-
glycemic).1 Researchers reviewed records 
to determine whether patients described 
as having an allergic reaction to a sulfon-
amide antibiotic were at increased risk of 
having a subsequent allergic reaction to 
a sulfonamide nonantibiotic. 
Patients were identified as being al-
lergic using both narrow definitions 
(anaphylaxis, bronchospasm, urticaria, 
laryngospasm, or angioedema) and 
broad ones. As only 18 patients out of 
the 20,226 patients were reported as 
having an allergic reaction using the nar-
row definition, analysis was based on 
the broad definition. Added to the broad 
category were asthma, eczema, and oth-
er “adverse” drug effects that were not 
specified by the author. 
Using this broad definition, research-
ers identified allergies to sulfonamide an-
tibiotics in 969 patients. Of this group, 96 
patients (9.9%) had a subsequent reaction 
to a sulfonamide nonantibiotic, which in-
cluded drugs from the loop and thiazide 
diuretic classes (including bumetanide, 
chlorothiazide, furosemide, hydrochloro-
thiazide, indapamide, and torsemide). It 
was unclear if any patients taking a car-
bonic anhydrase inhibitor experienced 
an allergic reaction. For comparison pur-
poses, of the 19,257 patients who were 
not identified as having an allergy to a 
sulfonamide antibiotic, again using the 
broad definition, 315 (1.6%), had a sub-
sequent allergic reaction to a sulfonamide 
nonantibiotic, for an unadjusted odds ra-
tio of 6.6 (95% confidence interval [CI], 
5.2–8.4).
When the results were adjusted for 
age, sex, history of asthma, use of medi-
cations for asthma or corticosteroids, the 
adjusted odds ratio for individuals ex-
periencing an allergy to a nonantibiotic 
sulfonamide in those persons with a his-
tory of allergy to a sulfonamide antibiotic 
was 2.8 (95 % CI, 2.1–3.7). Of note, the 
adjusted odds ratio for the occurrence 
of a penicillin allergy in a patient with a 
history of sulfonamide antibiotic allergy 
was significantly higher at 3.9 (95% CI, 
3.5–4.3). 
Some limitations of the study includ-
ed uncertainty of cause and effect of pre-
scribed medications and subsequent reac-
tions, possible inconsistency of physician 
diagnosis and coding, and lack of precision 
in the diagnosis of allergic reactions. There 
is also the possibility of “suspicion bias,” 
where patients with a history of allergies 
may be more closely monitored for subse-
quent reactions than nonallergic patients.
On	the	other	side,	small	studies		
reveal	little	risk	of	cross-reaction
Researchers involved in a retrospective 
study of 363 hospital charts examined 
34 patients with a self-reported history of 
sulfa allergy who were subsequently giv-
en acetazolamide (a carbonic anhydrase 
inhibitor), furosemide (a loop diuretic), 
or both.2 The nature of the self-reported 
sulfa allergic reaction was documented 
in 79% of the 34 patients. These re-
ported reactions included urticarial rash, 
nonspecified rash, dyspnea, swelling, 
nausea or vomiting, throat swelling, red 
eyes, and bullae. Two patients who were 
given acetazolamide developed urticaria. 
No allergic reactions occurred for those 
patients given furosemide. 
The researchers concluded that there 
was little clinical or pharmacological 
evidence to suggest that a self-reported 
sulfa allergy was likely to produce a life-
threatening cross-reaction with acetazol-
amide or furosemide. Small numbers and 
the lack of a standard definition for an 
allergic reaction limited the strength of 
their conclusion.
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A small single-blind study of 28 pa-
tients with a history of fixed drug erup-
tion to sulfonamide antibiotics examined 
the usefulness of patch testing as an al-
ternative to controlled oral challenge test-
ing.3 Before patch testing, a sulfonamide 
antibiotic allergy was confirmed by each 
patient with an oral challenge of sulfa-
methoxazole, sulfadiazine, or sulfameth-
azole. Potential cross-reactivity to several 
nonantibiotic sulfonamides (including 
furosemide) was also investigated using 
controlled oral challenge testing of these 
agents. Every patient tolerated a subse-
quent oral challenge with furosemide.
Literature	reviews	limited		
by	small	numbers
Two literature reviews examined the small 
number of case series, case reports, and 
“other articles” and concluded little evi-
dence supports the presence of cross-re-
activity between sulfonamide antibiotics 
and non-sulfonamide antibiotics.4,5 These 
reviews were limited by their search crite-
ria and lack of explicit critical appraisal.
A literature review of Medline from 
1966 to early 2004 revealed 21 case se-
ries, case reports, and “other articles” 
that evaluated the presence of cross-reac-
tivity.4 When the authors of this literature 
reviewed drilled down to diuretics, they 
found 5 case reports for cross-reactivity 
to acetazolamide, 2 case reports for furo-
semide, 1 case series, and 2 case reports 
for indapamide (a thiazide diuretic). 
After reviewing the studies, the authors 
concluded that little evidence suggested a 
problem with cross-reactivity either with 
acetazolamide or furosemide and that 
there may be an association of cross- 
reactivity between sulfonamide antibi-
otics and indapamide. This study was 
limited by its small numbers and lack of 
explicit critical appraisal.
In another literature review—in 
which the main focus was cross-reac-
tivity between sulfonamide antibiotics 
and celecoxib—the authors concluded 
that little evidence supported definitive 
cross-reactivity between sulfonamide 
antibiotics and diuretics.5 The limita-
tions of this study were similar to those 
of the previous study.
Recommendations	from	others
The manufacturer insert for furosemide 
states, under the heading “General Pre-
cautions,” that “patients allergic to sul-
fonamides may also be allergic to furo-
semide.”6 A similar warning occurs for 
hydrochlorothiazide under the heading 
“Contraindications.”7   n
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